Controlled substances: human chorionic gonadotropin.

California Assembly Bill 1152 updates the state's laws concerning controlled substances by specifically addressing human chorionic gonadotropin (hCG). This amendment clarifies the regulations surrounding hCG, which is often used in medical treatments and weight loss programs. The bill aims to ensure proper usage and control of this substance in healthcare settings.

Supporters of AB 1152 argue that the bill enhances patient safety by regulating the use of hCG more effectively. They believe that clearer guidelines will help medical professionals administer this substance appropriately, ultimately benefiting patients who rely on it for legitimate medical purposes.

Critics of AB 1152 may contend that the bill could restrict access to hCG for individuals seeking it for weight loss or other non-medical uses. They argue that the increased regulation may hinder personal choice and limit options for those who believe in the efficacy of hCG in their health and wellness routines.